Clinical Trial Update: Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D [NA]

View source ↗

Summary

A clinical trial is currently recruiting to evaluate central insulin sensitivity in adults with Type 2 diabetes and those at risk for developing diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Central Insulin Resistance, Diabetes Mellitus, Type 2 | NA | Status: RECRUITING